Oklahoma 2024 2024 Regular Session

Oklahoma House Bill HB2424 Introduced / Bill

Filed 01/19/2023

                     
 
Req. No. 6839 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 59th Legislature (2023) 
 
HOUSE BILL 2424 	By: May 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to opioid antagonists; amending 63 
O.S. 2021, Section 1 -2506.2, which relates to 
prescription of opioid antagonists to famil y members; 
replacing naloxone with opioid antagonist; amending 
63 O.S. 2021, Section 2 -312.2, which relates to the 
sale or dispensation of naloxone; removing naloxone 
and replacing it with opioid antagonist; and 
providing an effective date . 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 1 -2506.2, is 
amended to read as follows: 
Section 1-2506.2 A.  Upon request, a provider may prescribe an 
opioid antagonist to an individ ual for use by that individual when 
encountering a family member exhibiting signs of an opioid overdose. 
B.  When an opioid antagonist is prescribed in accordance with 
subsection A of this section, the provider shall provide: 
1.  Information on how to spot symptoms of an overdose; 
2.  Instruction in basic resuscitation techniques; 
3.  Instruction on proper naloxone opioid antagonist 
administration; and   
 
Req. No. 6839 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
4.  The importance of calling 911 nine-one-one (911) for help. 
C.  Any family member administering an opioid antagonist in a 
manner consistent with addressing opioid overdose shall be covered 
under the Good Samaritan Act. 
D.  Any provider prescribing o r administering an opioid 
antagonist in a manner con sistent with addressing opioid overdose  
SECTION 2.     AMENDATORY     63 O.S. 2021, Section 2 -312.2, is 
amended to read as follows: 
Section 2-312.2 Naloxone, also known as Narcan, or any of its 
generic equivalents Any opioid antagonist that is approved by the 
United States Food and Drug Admini stration may be dispensed or sold 
by a pharmacy without a prescription; provided, however, it shall be 
dispensed or sold only by, or under the supervi sion of, a licensed 
pharmacist.  Naloxone An opioid antagonist may be prescribed and 
dispensed by a licens ed pharmacist; provided, however, it shall be 
dispensed only by, or under the supervision of, a licensed 
pharmacist.  No dispensing protocol shall be required. 
SECTION 3.  This act shall become effective November 1, 2023. 
 
59-1-6839 TJ 01/11/23